CGM Integration Program for Diabetes

(INSIDE-CGM Trial)

This trial explores how well different training programs help older adults using insulin integrate continuous glucose monitors (CGMs) into their daily lives. Researchers will randomly divide participants into three groups to test various training methods: a detailed multi-session program (three-stage CGM integration program), a one-time clinic session, and self-guided learning with a pamphlet. The goal is to determine if these training methods improve CGM usage, blood sugar management, and participants' feelings about their diabetes care. The trial seeks adults aged 65 and older who use insulin, have not used a CGM in the past year, and are open to using a smartphone for glucose readings. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance diabetes care for older adults.

The trial information does not specify if you need to stop taking your current medications. However, if a medication might affect your ability to complete the study, the investigator may decide it's best not to include you in the trial.

Research shows that the three-stage continuous glucose monitor (CGM) program is generally easy for participants to handle. Previous studies have found that programs using CGM devices, like the one in this study, usually have manageable side effects. These devices help people with diabetes monitor their blood sugar levels in real-time and are commonly used in diabetes care.

Researchers are excited about the CGM Integration Program for diabetes because it offers a structured, three-stage approach to continuous glucose monitor (CGM) integration, setting it apart from current options. Unlike standard methods, which often rely on self-directed or one-time training, this program provides a more comprehensive and supportive framework for users. By gradually guiding individuals through the stages of CGM use, the program aims to enhance user proficiency and confidence, potentially leading to better blood sugar management. This innovative approach could result in improved outcomes for people with diabetes, making it a promising development in diabetes care.

Research has shown that continuous glucose monitors (CGMs) effectively manage diabetes. They help lower HbA1C levels, leading to better long-term blood sugar control. Studies indicate that CGMs enable people to maintain their blood sugar within a healthy range more often and reduce episodes of dangerously low blood sugar. Some CGMs provide real-time data, further enhancing blood sugar management. Overall, using a CGM simplifies tracking and managing diabetes, resulting in better health outcomes.